# Niacin + Lovastatin

## Linicor 500/20mg

##### 

| 藥品代碼   | OLINI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Primary hypercholesterolemia/mixed dyslipidemia: Treatment of primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson types IIa and IIb) in combination with a standard cholesterol-lowering diet.                                                                                                                                                                                                                                                                                                                                    |
| 用法用量   | Dosing: Adult Dosage (forms are a fixed combination of niacin 500mg and lovastatin 20mg). Primary hypercholesterolemia/mixed dyslipidemia: Oral: Lowest dose: Niacin extended release 500 mg/lovastatin 20 mg once daily at bedtime with a low-fat snack; may increase by not more than 500 mg (niacin extended release) once daily at bedtime at 4-week intervals (maximum dose: niacin extended release 2000 mg/lovastatin 40 mg daily). Note: If therapy is interrupted for >7 days， reinstitution of therapy should begin with the lowest dose followed by retitration as needed. |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌       | Hypersensitivity to lovastatin， niacin， or any component of the formulation; active liver disease; unexplained persistent elevations of serum transaminases; active peptic ulcer disease; arterial bleeding; pregnancy; breast-feeding; concomitant use of strong CYP3A4 inhibitors (eg， clarithromycin， erythromycin， itraconazole， ketoconazole， nefazodone， posaconazole， voriconazole， protease inhibitors including boceprevir and telaprevir， telithromycin， and cobicistat-containing products)                                                                     |
| 副作用     | >10%: Cardiovascular: Flushing (53% to 83%) Infection: Infection (20%) 1% to 10%: Central nervous system: Headache (9%)， pain (8%) Dermatologic: Pruritus (7%)， skin rash (5%) Endocrine & metabolic: Hyperglycemia (4%)， hypophosphatemia Gastrointestinal: Nausea (7%)， diarrhea (6%)， abdominal pain (4%)， dyspepsia (3%)， vomiting (3%) Hematologic & oncologic: Increased prothrombin time (2%) Respiratory: Flu-like symptoms (6%)                                                                                                                                        |
| 孕期建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

